UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Meet Our Section Editor

Current cancer drug targets, 2020-02, Vol.20 (2), p.85-85

Ilhan-Mutlu, A.

2020

Volltextzugriff (PDF)

A comparison of the utilization and efficacy of palliative chemotherapy for the treatment of locally advanced or metastatic gastroesophageal carcinoma: a retrospective single-center analysis

Annals of oncology, 2019-07, Vol.30, p.iv67-iv67

2019

Volltextzugriff (PDF)

How we treat esophageal squamous cell carcinoma

ESMO open, 2023-02, Vol.8 (1), p.100789, Article 100789

2023

Volltextzugriff (PDF)

Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis

Cancer biology & therapy, 2018-03, Vol.19 (3), p.169-174

2018

Volltextzugriff (PDF)

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases

Strahlentherapie und Onkologie, 2014-07, Vol.190 (7), p.676-685

2014

Volltextzugriff (PDF)

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

European journal of cancer (1990), 2023-05, Vol.185, p.28-39

2023

Volltextzugriff (PDF)

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

British journal of cancer, 2012-10, Vol.107 (9), p.1454-1458

2012

Volltextzugriff (PDF)

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)

ESMO open, 2022-08, Vol.7 (4), p.100519-100519, Article 100519

2022

Volltextzugriff (PDF)

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases

Neuropathology and applied neurobiology, 2015-02, Vol.41 (2), p.e41-e55

2015

Volltextzugriff (PDF)

1428P Circulating nutritional biomarkers and their association with survival in patients with metastatic gastroesophageal cancer

Annals of oncology, 2021-09, Vol.32, p.S1068-S1068

2021

Volltextzugriff (PDF)

1400P Initial symptoms and their association with survival in patients with stage II-III gastroesophageal adenocarcinoma

Annals of oncology, 2021-09, Vol.32, p.S1056-S1057

2021

Volltextzugriff (PDF)

468P Association of prior and concurrent malignancies with overall survival in a large European single-center gastroesophageal cancer cohort

Annals of oncology, 2024-06, Vol.35, p.S187-S187

2024

Volltextzugriff (PDF)

P-231 Systemic inflammatory biomarkers and their association with survival in gastroesophageal cancer patients: A retrospective single-center analysis

Annals of oncology, 2021-07, Vol.32, p.S178

2021

Volltextzugriff (PDF)

1242P Thromboembolic events and their association with the overall survival in a large European cohort with gastroesophageal cancer

Annals of oncology, 2022-09, Vol.33, p.S1116-S1117

2022

Volltextzugriff (PDF)

1236P Comorbidities and their association with the overall survival in a large European cohort with gastroesophageal cancer

Annals of oncology, 2022-09, Vol.33, p.S1114

2022

Volltextzugriff (PDF)

P-175 Local inflammatory biomarkers and their association with systemic inflammation as well as overall survival in primary metastatic gastroesophageal cancer patients

Annals of oncology, 2022-06, Vol.33, p.S312

2022

Volltextzugriff (PDF)

P-243A comparison of the utilization and efficacy of palliative chemotherapy for the treatment of locally advanced or metastatic gastroesophageal carcinoma: a retrospective single-center analysis

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

1462P Prognostic impact of clinical and laboratory nutritional markers in resectable gastroesophageal cancer

Annals of oncology, 2020-09, Vol.31, p.S916-S916

2020

Volltextzugriff (PDF)

465P Timing of first-line palliative systemic therapy in metastatic Esophagogastric cancer (mEGC): A European Delphi study

Annals of oncology, 2024-06, Vol.35, p.S186-S187

2024

Volltextzugriff (PDF)

165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial

Annals of oncology, 2022-05, Vol.33, p.S198-S198

2022

Volltextzugriff (PDF)

1487P Prognostic impact of thyroid hormone status in resectable gastroesophageal cancer

Annals of oncology, 2020-09, Vol.31, p.S924-S924

2020

Volltextzugriff (PDF)

280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial

Annals of oncology, 2021-09, Vol.32, p.S486-S486

2021

Volltextzugriff (PDF)

Circulating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients

Annals of oncology, 2019-10, Vol.30, p.v145

2019

Volltextzugriff (PDF)

395PDCirculating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(161)
Türkisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Meet Our Section Editor

A comparison of the utilization and efficacy of palliative chemotherapy for the treatment of locally advanced or metastatic gastroesophageal carcinoma: a retrospective single-center analysis

How we treat esophageal squamous cell carcinoma

Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis

Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastases

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)

Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases

1428P Circulating nutritional biomarkers and their association with survival in patients with metastatic gastroesophageal cancer

1400P Initial symptoms and their association with survival in patients with stage II-III gastroesophageal adenocarcinoma

468P Association of prior and concurrent malignancies with overall survival in a large European single-center gastroesophageal cancer cohort

P-231 Systemic inflammatory biomarkers and their association with survival in gastroesophageal cancer patients: A retrospective single-center analysis

1242P Thromboembolic events and their association with the overall survival in a large European cohort with gastroesophageal cancer

1236P Comorbidities and their association with the overall survival in a large European cohort with gastroesophageal cancer

P-175 Local inflammatory biomarkers and their association with systemic inflammation as well as overall survival in primary metastatic gastroesophageal cancer patients

P-243A comparison of the utilization and efficacy of palliative chemotherapy for the treatment of locally advanced or metastatic gastroesophageal carcinoma: a retrospective single-center analysis

1462P Prognostic impact of clinical and laboratory nutritional markers in resectable gastroesophageal cancer

465P Timing of first-line palliative systemic therapy in metastatic Esophagogastric cancer (mEGC): A European Delphi study

165MO Trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients (pts) with active brain metastases: Primary outcome analysis from the TUXEDO-1 trial

1487P Prognostic impact of thyroid hormone status in resectable gastroesophageal cancer

280P Intracranial activity of trastuzumab-deruxtecan (T-DXd) in HER2-positive breast cancer patients with active brain metastases: Results from the first stage of the phase II TUXEDO-1 trial

281MO Quality of life and neurocognitive function in patients with active brain metastases of HER2-positive breast cancer treated with trastuzumab-deruxtecan: Secondary endpoint analysis of the prospective single-arm phase II TUXEDO-1 trial

Circulating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients

395PDCirculating PD-L1 levels vary across brain tumour entities and are oppositely linked to survival in glioblastoma and lower grade glioma patients

Suchergebnisse filtern